Pharmacoeconomic Analysis of the use of Everolimus Compared to Axitinib in Second Line Therapy of Patients with Metastatic Renal Cell Carcinoma
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1090
https://www.valueinhealthjournal.com/article/S1098-3015(15)03166-6/fulltext
Title :
Pharmacoeconomic Analysis of the use of Everolimus Compared to Axitinib in Second Line Therapy of Patients with Metastatic Renal Cell Carcinoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03166-6&doi=10.1016/j.jval.2015.09.1090
First page :
A442
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
590